Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / COMMON STOCK, PAR V ALUE $0.001 PER SHARE
-
Shares outstanding
-
79,310,345
-
Number of holders
-
64
-
Total 13F shares, excl. options
-
10,770,110
-
Shares change
-
-454,575
-
Total reported value, excl. options
-
$44,582,136
-
Value change
-
-$1,863,278
-
Put/Call ratio
-
152%
-
Number of buys
-
26
-
Number of sells
-
-25
-
Price
-
$4.14
Significant Holders of CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD) as of Q1 2023
78 filings reported holding CRMD - CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE as of Q1 2023.
CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD) has 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10,770,110 shares
of 79,310,345 outstanding shares and own 14% of the company stock.
Largest 10 shareholders include NOMURA HOLDINGS INC (2,951,532 shares), VANGUARD GROUP INC (1,937,761 shares), Elliott Investment Management L.P. (1,550,523 shares), BlackRock Inc. (643,155 shares), GEODE CAPITAL MANAGEMENT, LLC (373,980 shares), MILLENNIUM MANAGEMENT LLC (312,972 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (252,325 shares), MARSHALL WACE, LLP (201,399 shares), RENAISSANCE TECHNOLOGIES LLC (181,724 shares), and Spinnaker Capital LLC (175,384 shares).
This table shows the top 64 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.